Tom H. Johnston
60 Leonard Ave
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.
Journal: Science translational medicine
Published: July 15, 2026
Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesia.
Journal: Neuropharmacology
Published: June 14, 2023
A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease.
Journal: Experimental neurology
Published: August 12, 2020
The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques.
Journal: Parkinsonism & related disorders
Published: June 02, 2020
NYX-458 Improves Cognitive Performance in a Primate Parkinson's Disease Model.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 16, 2019
Beneficial Effects of Trehalose on Striatal Dopaminergic Deficits in Rodent and Primate Models of Synucleinopathy in Parkinson's Disease.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 06, 2018
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 17, 2018
Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
Journal: Neuropharmacology
Published: April 05, 2018
Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia.
Journal: The Journal of pharmacology and experimental therapeutics
Published: January 03, 2018
DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.
Journal: Neuropharmacology
Published: June 16, 2017
Last Updated: 09/26/2026